Logo.png
Pancreatic Cancer Market to Grow Rapidly by 2034, Predicts DelveInsight | Key Companies - FibroGen, OSE Immunotherapeutics, Panbela Therapeutics, Lokon Pharma, Helix Biopharma, Tvardi Therapeutics, BioNTech, XBiotech, Lumicell, CARsgen Ther
09 juil. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, July 09, 2024 (GLOBE NEWSWIRE) -- Pancreatic Cancer Market to Grow Rapidly by 2034, Predicts DelveInsight | Key Companies - FibroGen, OSE Immunotherapeutics, Panbela Therapeutics,...
finacialnews-logo-final-01 (2).png
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
20 juin 2024 10h00 HE | FN Media Group LLC
PALM BEACH, Fla., June 20, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The National Cancer Institute’s (NCI) funding of research projects is predicted to empower the Pancreatic Cancer...
finacialnews-logo-final-01 (2).png
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033
20 juin 2024 08h45 HE | FN Media Group LLC
PALM BEACH, Fla., June 20, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Pancreatic cancer is among the most frequently diagnosed and the seventh leading cause of cancer death globally....
ElmediX_blue_horizontal
ElmediX Plans Series A Round Based on Strong Signals in a Clinical Study for Pancreatic Cancer Patients at the University Hospital Antwerp (Belgium)
14 juin 2024 08h03 HE | Elmedix
A novel and innovative approach to treating metastasized cancer, starting with the very lethal grade 4 pancreatic cancer.  Earlier this year, scientists from Columbia University in New...
Immuneering-logo (1).png
Immuneering to Present at the Jefferies Global Healthcare Conference
29 mai 2024 16h05 HE | Immuneering Corporation
Immuneering to Present at the Jefferies Global Healthcare Conference
logo_urteste.png
Urteste has successfully developed a prototype urine-based diagnostic test for detecting brain tumours
28 mai 2024 06h24 HE | Urteste S.A.
28 MAY 2024        PRESS RELEASE Urteste has successfully developed a prototype urine-based diagnostic test for detecting brain tumours Gdańsk, Poland – 28 MAY 2024, Urteste S.A. (Warsaw Stock...
finacialnews-logo-final-01 (2).png
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
24 mai 2024 08h45 HE | FN Media Group LLC
PALM BEACH, Fla., May 24, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The pancreatic cancer market encompasses the pharmaceutical and healthcare sectors dedicated to addressing the...
logo.png
Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer
23 mai 2024 09h15 HE | Autonomix Medical, Inc.
Results from the preclinical study demonstrated statistically significant reduction of metastases and statistically significant reduction in tumor mass Lori Bisson, Chief Executive Officer...
Immuneering-logo (1).png
Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates
07 mai 2024 16h05 HE | Immuneering Corporation
Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates
Immuneering-logo (1).png
Immuneering Recognizes Melanoma Awareness Month
06 mai 2024 16h30 HE | Immuneering Corporation
Immuneering Recognizes Melanoma Awareness Month